VEGF depletion enhances bcr-abl-specific sensitivity of arsenic trioxide in chronic myelogenous leukemia

By Luo Xiaochuang   Feng Maoxiao   Zhu Xuejiao   Li Yumin   Fei Jia   Zhang Yuan  

Hematology, Vol. 18, Iss. 6, 2013-11 ,pp. : 333-339

Maney Publishing

Access to resources Recommend Favorite

Reconsideration of BCR‐ABL protein flow cytometric immunobead assay: how potent to diagnose and monitor chronic myeloid leukemia?

By  

International Journal Of Laboratory Hematology, Vol. 37, Iss. 5, 2015-10 ,pp. : 723-728

John Wiley & Sons Inc

Access to resources Recommend Favorite

Targeting the Kinase Activity of the BCR-ABL Fusion Protein in Patients with Chronic Myeloid Leukemia

By  

Current Molecular Medicine, Vol. 5, Iss. 7, 2005-11 ,pp. : 615-623

Bentham Science Publishers

Access to resources Recommend Favorite

Identification of T-cell clones showing expansion associated with graft-vs-leukemia effect on chronic myelogenous leukemia in vivo and in vitro

By Kondo Y.   Shiobara S.   Nakao S.  

Experimental Hematology, Vol. 29, Iss. 4, 2001-04 ,pp. : 471-476

Elsevier

Access to resources Recommend Favorite

Lower than expected cytogenetic and molecular response to imatinib in Mexican patients with chronic myelogenous leukemia

By Gutierrez-Aguirre Cesar Homero   Garcia-Rodriguez Fernando   Ortiz-Galvez Victor Manuel   Cantu-Rodriguez Olga Graciela   Salazar-Riojas Rosario   Martinez-Gonzalez Odra Lizzette   Gonzalez-Llano Oscar   Jaime-Pérez Jose Carlos   Ortiz-Lopez Rocio   Flores-Jimenez Juan Antonio   Alatorre-Ricardo Julio   Mancias-Guerra Consuelo   Gomez-Almaguer David  

Hematology, Vol. 18, Iss. 4, 2013-07 ,pp. : 224-229

Maney Publishing

Access to resources Recommend Favorite